Charles Tacquard

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Systematic Review

Dna Methylation

Cardiac Surgery

Top Venues

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Guillaume Pouessel, Charles Tacquard, Luciana Kase Tanno, Paul Michel Mertes, Guillaume Lezmi
Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (1) (2024)
Guillaume Pouessel, Charles Tacquard, Luciana Kase Tanno, Paul Michel Mertes, Guillaume Lezmi
Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (1) (2024)
Guillaume Pouessel, Charles Tacquard, Luciana Kase Tanno, Paul Michel Mertes, Guillaume Lezmi
Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (1) (2024)
Guillaume Pouessel, Charles Tacquard, Luciana Kase Tanno, Paul Michel Mertes, Guillaume Lezmi
Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2024)
Charles Tacquard, Florian Tupin, Stéphanie Magnenat, Nathalie Brouard, Anita E Eckly, Fabienne Proamer, Carine Metz-Favre, Rodolphe Stenger, Anays Piotin, Fréderic de Blay, Didier Gaston Ebo, Jessy Elst, Paul Michel Mertes, Béatrice Hechler
Human platelets do not possess the FcεRI and FcεRII receptors for IgE. Allergy (2023)
Charles Tacquard, Walid Oulehri, Olivier Collange, Lene H Garvey, Susan Nicoll, Nicolas Tuzin, Bernard Geny, Paul M Mertes
Treatment with a platelet-activating factor receptor antagonist improves hemodynamics and reduces epinephrine requirements, in a lethal rodent model of anaphylactic shock. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 50 (3) (2019)